Medical Image Management Market Insights on Scope and Growing Demands 2023

According to research report the medical image management market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.

The growth of the market is driven by the technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, and the growing adoption of image management systems by small hospitals and imaging centers, are factors driving the growth of the medical image management market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338

The report segments the medical image management system market by product, end user, and region.

Based on products, the medical image management market is segmented into PACS, VNAs, AICA, and enterprise/universal viewers. The PACS segment is expected to account for the largest share of the market in 2018. Factors such as technological advancements in PACS: adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging Healthcare IT adoption are driving the growth of the PACS segment.

On the basis of type, the PACS market is segmented into radiology PACS, cardiology PACS, and other departmental PACS which include PACS solutions for specialties such as ophthalmology, pathology, oncology, radiotherapy, endoscopy, and dentistry. In 2018, the radiology PACS held the largest share of the market as the radiology department of a hospital is where a majority of the imaging studies are handled, managed, and stored.

The medical image management market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users. In 2018, the hospitals segment is expected to account for the largest share of the global medical image management system market. The rising patient population, growing awareness about the benefits of early disease diagnosis, increasing digitization of patient data, and rapid growth in EMR adoption are some of the major factors responsible for the large share of the hospitals segment in the market.

The medical image management market is marked by the presence of several big and small players. Prominent players offering medical image management products include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd. (South Korea).

Request For Sample of the Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=240573338

The medical image management system market is dominated by North America, followed by Europe. The dominance of the North American market is attributed to factors such as the large number of imaging centers in this region, ongoing research activities, and rapid adoption of technologically advanced imaging systems. Additionally, government initiatives towards digitization and increasing adoption of EHR/EMR and data storage & exchange solutions are additional factors driving the adoption of medical image management in this region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Cancer Immunotherapy Market Insights on Scope and Growing Demands 2021

According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%.

This growth can be attributed to factors such as increasing adoption of target therapy over traditional therapy, emergence of biosimilars, increasing demand for mAbs, high prevalence of cancer.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894

The Lung Cancer application segment is expected to grow at a high CAGR during the forecast period

The current immunotherapies for lung cancer treatment, such as checkpoint inhibitors, monoclonal antibodies, therapeutic vaccines, and other cell therapies, have benefited some patients with advanced lung cancer in the form of durable remission and prolonged survival. The Lung Cancer segment is expected to grow at a high CAGR from 2016 to 2021, owing to the increase in prevalence, patient pool urges a demand for advanced treatment options, and this increases the growth of Cancer Immunotherapy market.

The monoclonal antibody segment is expected to lead the market during the forecast period

Monoclonal antibodies are emerging as the most effective therapeutic agents for the treatment of malignancy. They are currently one of the largest classes of agents approved for the treatment of cancer. Several antibodies are widely adopted, owing to their lesser side effects as compared to chemotherapy. Antibodies are developed to treat several cancers such as lymphoma, leukemia, melanoma, breast cancer, and lung cancer. Cancer monoclonal antibodies are sub-segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies.

Increase in adoption of immunotherapy over other treatment options is driving the growth of this market

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

Critical questions the report answers:

> Where will all these developments take the industry in the mid to long term?
> What are the upcoming applications for cancer immunotherapy?

While immunotherapy has shown significant promise in the area of cancer treatment, its high cost has served to limit overall patient access. This poses a significant financial burden on low- and middle-income cancer patients. This is restricting the cancer immunotherapy market from growing at its full potential.

The major players in the cancer immunotherapy market are Amgen (U.S.), AstraZeneca (U.K.), F. Hoffman La-Roche (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).

Target Audience for this Report:

> Drug Manufacturers and Suppliers
> Academic Research Institutes
> Hospitals and Clinics
> Research and Development (R&D) Companies
> Business Research and Consulting Service Providers
> Medical Research Laboratories
> Academic Medical Centers and Universities

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197577894

Geographically, the North American market accounted for the largest share of the global cancer immunotherapy market in 2016. The large share can be attributed to factors such as rising number of patients suffering from cancer, increasing adoption rate of immunotherapy, and development of bioinformatics tools are enhancing the drug development process.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Hyperspectral Imaging Systems Market Insights on Scope and Growing Demands 2025

According to the new market research report hyperspectral imaging systems market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.

The increasing funding and investments, growing industrial applications of hyperspectral imaging are the major factors driving the growth of the hyperspectral imaging systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343

The Snapshot technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the hyperspectral imaging systems market is segmented into pushbroom (line-scanning), snapshot (single shot), and other technologies [whiskbroom (point-scanning), tunable filters (wavelength scan), and imaging FTIR (time scanning)]. The pushbroom segment is estimated to account for the largest share of the hyperspectral imaging market in 2019, while the snapshot segment is projected to register the highest CAGR during the forecast period. This can be attributed to the advantages offered by snapshot hyperspectral imaging systems, which make this technology most suitable for real-time analysis.

PERSONALIZE THIS RESEARCH

> Triangulate with your Own Data
> Get Data as per your Format and Definition
> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
> Any level of Personalization

In 2019, the cameras segment accounted for the largest share of the market

On the basis of product, the Hyperspectral Imaging Market is segmented into cameras and accessories. Cameras are expected to command the larger share of the market, by product, in 2019. Technological advancements, the development of affordable hyperspectral imaging cameras, and the increasing adoption of hyperspectral technology for defense and industrial applications are driving the growth of the hyperspectral cameras segment.

The prominent players operating in the hyperspectral imaging systems market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), BaySpec, Inc. (US), Cubert GmbH (Germany), inno-spec GmbH (Germany), XIMEA GmbH (Germany), imec (Belgium), and ChemImage Corporation (US).

Recent Developments

> In 2019, Headwall Photonics launched its advanced sensor payloads (consisting of hyperspectral sensors and LIDAR for unmanned aerial vehicle platforms)
> In 2018, SPECIM opened a new facility in Espoo, Finland
> In 2018, Telops signed a distribution agreement with Infrared Imaging LLC. This agreement strengthened the position of Telops in the US market.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343

North America was the largest regional market for hyperspectral imaging systems in 2019.

The hyperspectral imaging systems market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. Factors such as growth in research funding, technological advancements, and increasing awareness of the benefits of hyperspectral imaging in commercial industries across the region are driving the market for hyperspectral imaging systems in North America.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Surgical Microscopes Market Insights on Scope and Growing Demands 2021

According to research report surgical microscopes market is poised to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, at a CAGR of 12.5% from 2016 to 2021.

Growth in this market can mainly be attributed to factors such as the increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179225920

The global operating microscopes market is segmented on the basis of application, end user, and region.

Based on application, the global surgical/operating microscopes market is categorized into dentistry, ENT (ear, nose, and throat) surgery, gynecology and urology, neuro and spine surgery, oncology, ophthalmology, plastic and reconstructive surgery, and documentation. In 2016, the neuro and spine surgery segment is estimated to account for the largest share of the global surgical/operating microscopes market. Oncology forms the fastest-growing segment.

On the basis of end user, the surgical microscopes market is segmented into hospitals and outpatient facilities. In 2016, hospitals are estimated to account for the largest share of the operating microscopes market. The growing usage of surgical/operating microscopes in complex neurology, ENT, and dental procedures, and implementation of less-invasive surgical instruments during MIS procedures in hospitals are key market drivers in this end-user segment.

The surgical microscopes market is highly competitive in nature. Some of the major players in this market include Novartis Ag (Switzerland), Danaher Corporation (U.S.), Topcon Corporation (Japan), Carl Zeiss AG (Germany), Hagg-Streit Surgical GMBH (MÖLLER-WEDEL GMBH) (Germany) Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Karl Kaps GmbH & Co. Kg, Takagi Seiko Co. Ltd.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=179225920

In 2016, North America is expected to account for the largest share of the global surgical microscopes market. Factors such as the growing demand for minimally invasive surgical procedures, infrastructural advancements in healthcare facilities, and increase in the number of surgeries are driving the growth of the North American operating microscopes market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Genome Editing Market worth $11.2 billion by 2025

According to the new market research report "Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Genome Engineering Market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000

The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

By technology, the CRISPR segment accounted for the largest share for the genome editing market.

The CRISPR technology segment accounted for the largest share of the genome editing/genome engineering industry in 2019. The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN. Another potential advantage is its ability to multiplex.

By end user, the pharmaceutical companies segment accounted for the largest share of the market.

Pharmaceutical companies accounted for the largest share of the genome engineering market, by end user, in 2019. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide. This, in turn, is expected to drive the demand for genome editing in pharmaceutical companies.

By application, the cell line engineering segment accounted for the largest share of the market

Based on application, the genome editing market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications. A number of factors, such as the increased funding from governments and private organizations, growing industry focus on stem cell research, and global awareness are driving market growth in this segment.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231037000

North America accounted for the largest share of the market.

The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global genome engineering market, closely followed by Europe. The large share of North America can be attributed to factors such as the development of gene therapy in the US, the increasing use of genetically modified crops, the rising prevalence of infectious diseases and cancer, and the availability of research grants and funding.

The market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period, primarily due to increasing investments in research and the application of gene synthesis for genetic engineering in cells, tissues, and organisms.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Veterinary Reference Laboratory Market Insights on Scope and Growing Demands 2025

 According to research report the veterinary reference laboratories market size is projected to reach USD 5.6 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 10.5%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256972714

Factors such as increasing demand for animal-derived food products and increasing incidence of transboundary and zoonotic diseases are driving the growth of this market amongst the livestock animals during the forecast period.

The veterinary reference lab market is segmented based on the type of service, application, animal, and region. Due to lockdown restrictions and social distancing protocols due to COVID-19 across various countries through the first half of 2020, the market saw a small dip in the number of veterinary clinic visits for routine testing. However, with the launch of new test kits for COVID-19 testing in pets, the second half of the year is expected to see a rise in the total number of tests in reference laboratories, thus compensating for the loss in revenues across the first two quarters.

The immunodiagnostics segment accounted for the largest share of the veterinary reference lab market, by type of service, in 2019.

Based on the type of service, the market is segmented into clinical chemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and others. In 2019, the immunodiagnostics segment accounted for the largest share of the veterinary reference laboratories market. The low cost, low procedural complexity, and greater adoption due to ease of training are some of the key advantages supporting the adoption of this service.

Clinical pathology is the largest application segment of the veterinary reference laboratories market

Based on application, the veterinary reference laboratories market is segmented into clinical pathology, bacteriology, virology, parasitology, productivity testing, pregnancy testing, and toxicology. In 2019, the clinical pathology segment accounted for the largest market share. The rising volume of pathology tests performed is the major factor driving the demand for diagnostic products and consumables for clinical pathology applications.

The companion animal segment accounted for the larger market in 2019.

Based on animal type, the veterinary reference lab market is segmented into livestock animals and companion animals. In 2019, the companion animal segment accounted for the larger share of this market. Growth in this segment is attributed to the growing adoption of companion animals, increasing disposable incomes, growing willingness of companion animal owners to spend more on animal health, and rising incidence of zoonotic diseases.

IDEXX Laboratories, Inc. (US), VCA Inc. (US), GD Animal Health (Netherlands), Zoetis Inc. (US), Neogen Corporation (US), Boehringer Ingelheim (Germany), Marshfield Labs (US), ProtaTek International (US), Texas A&M Veterinary Medical Diagnostic Laboratory (US), Veterinary Diagnostic Laboratory - University of Minnesota (US), and Veterinary Diagnostic Laboratory, Iowa State University (US).

Recent Developments

> In April 2020, IDEXX launched the SARS-CoV-2 (COVID-19) RealPCR Test for companion animals in the US.
> In 6-9 months since October 2019, Zoetis acquired three laboratories that have enhanced the company’s portfolio of testing services with the introduction of microbiology, serology, hematology, chemistry, and many other miscellaneous tests.
> In June 2018, Boehringer Ingelheim acquired Newport Laboratories. The service portfolio of Newport Laboratories is expected to complement BI’s animal business unit portfolio and provide a complete solution for disease prevention in livestock animals.
> In September 2017, Mars, Inc. acquired VCA, Inc. in an all-cash transaction. VCA is now functioning as a separate business unit under Mars Petcare. This acquisition helped Mars in delivering comprehensive solutions in the field of animal testing services.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=256972714

The veterinary reference laboratories market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the ever-increasing number of veterinary practices are driving the growth of the North American veterinary reference lab market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Spatial Genomics Market Insights on Scope and Growing Demands 2025

According to the new market research report the global spatial genomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551

The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R&D investments and public-private funding. Additionally, the introduction of technologically advanced instruments for spatial genomics analysis is also boosting the market growth. However, the high capital investments associated with spatial genomics and transcriptomics are a major factor restraining market growth.

Spatial Genomics Market is categorized into major four product categories, techniques, product, application and end user. Among the techniques, spatial transcriptomics techniques segment is expected to grow at the highest CAGR during the forecast period. Growth in this market segmentis attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.

On the basis of technique, the spatial genomics & transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. The spatial transcriptomics techniques segment is further sub-segmented into immunohistochemistry (IHC), in situ hybridization, sequencing technologies, microscopy-based RNA imaging, and other spatial transcriptomics techniques.

Among these, immunohistochemistry segment held a dominant share owing to emergence of multiplex immunohistochemistry/ immunofluorescence (mIHC/IF). Furthermore, spatial genomics analysis technique segment is further sub-segmented into into fluorescence in situ hybridization (FISH), sequencing techniques, and other spatial genomics analysis techniques. The increasing demand for new biomarkers for diagnosis and personalized medicine is a major factor boosting the demand for spatial genomics analysis as a cancer diagnostic tool.

Based on product, the global spatial genomics & transcriptomics market is categorized instruments, consumables, and software. In 2019, consumables accounted for the largest share in the global spatial genomics and transcriptomics market. The growing applications of spatial genomics and transcriptomics in various fields such as drug discovery & development and biomarker identification and the growing use of consumables are the key factors driving the market growth.

Based on application, the spatial genomics & transcriptomics market is segmented translational research and drug discovery & development. The translational research application segment accounted for the largest share of the market in 2019.

The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

Based on end users, the spatial genomics market is segmented into into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2019, the academic & research institutes segment accounted for the largest share of the spatial genomics and transcriptomics market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.

10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the spatial genomics and transcriptomics market.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551

In 2019, North America held the largest share of 55.6% of the global market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics and transcriptomics market in this region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com